Mission magazine banner

$3 million from NIH supports diabetes trial

May 2004

The Texas Diabetes Institute (TDI), where faculty and staff from the Health Science Center and medical staff of the University Health System treat patients, is one of 12 sites nationwide selected to recruit children ages 10 to 17 into the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) study for the purpose of comparing three treatments for type 2 diabetes metformin alone, metformin and rosiglitazone together, and metformin plus intensive lifestyle change to lose weight and increase exercise. A $3 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases supports the San Antonio site.

The San Antonio investigators seek to enroll more than 60 young people who have been diagnosed with type 2 diabetes in the last two years, including many from Hispanic and African-American families in Bexar and surrounding counties. Study-related medical care and medications are provided at no cost.

"The TDI, the largest center focusing solely on diabetes in the country, is the perfect place to recruit the children and teens who will benefit from this important clinical study," said local Principal Investigator Daniel Hale, M.D., professor of pediatrics and chief of the division of pediatric endocrinology and diabetes at the Health Science Center and pediatric medical director at the TDI.

The TDI is located at the University Center for Community Health at
701 S. Zarzamora. For more information about the TODAY study,
call toll-free 1-866-764-6450.


More stories:

Read current stories



Previous Issues

Current Issue (PDF)


Email us

HSC News

Make a Gift

University Home

UT Health Science Center
7703 Floyd Curl Dr.
San Antonio, Texas

© 2002 - 2015 UTHSCSA
Office of Communications
All rights reserved.

Links provided from UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.

Updated 12/11/14